Показано 0 из 0
Дата |
---|
17:17 |
01.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
4.32
|
4.38
|
4.48
|
4.30
|
4.53
|
4.34
|
|
|
29 261.53
|
96.00
|
4.40
|
4.48
|
3.96
|
3.96
|
4.56
|
4.39
|
|
|
734 350.24
|
1 346.00
|
3.86
|
3.95
|
4.11
|
3.865
|
4.11
|
3.925
|
|
|
184 140.03
|
483.00
|
4.04
|
4.09
|
4.08
|
3.94
|
4.20
|
4.085
|
|
|
183 608.72
|
495.00
|
3.96
|
4.00
|
3.88
|
3.87
|
4.01
|
3.99
|
|
|
105 304.24
|
373.00
|
3.82
|
3.92
|
3.78
|
3.71
|
3.915
|
3.90
|
|
|
207 479.09
|
582.00
|
3.80
|
3.82
|
3.99
|
3.70
|
4.03
|
3.82
|
|
|
286 211.85
|
632.00
|
3.93
|
3.95
|
3.83
|
3.755
|
4.155
|
3.93
|
|
|
529 591.87
|
1 168.00
|
3.74
|
3.78
|
3.88
|
3.305
|
3.88
|
3.70
|
|
|
541 251.62
|
901.00
|
3.78
|
3.80
|
3.71
|
3.55
|
4.11
|
3.70
|
|
|
737 633.54
|
1 713.00
|
Humacyte Inc (formerly Alpha Healthcare Acquisition Corp) is a developer of a biotechnology and regenerative medicine platform intended to provide potential commercialization for key applications in regenerative medicine and vascular surgery. The company's platform utilizes technology to engineer human, extracellular matrix-based tissues that can be shaped into tubes, sheets, or particulate conformations, with properties similar to native tissues, enabling patients to significantly improve treatment outcomes, including those with vascular disease and those requiring hemodialysis.